Search | IOVS | ARVO Journals

Showing 1 – 20 of 67

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Treatment efficacy of adalimumab in ocular sarcoidosis – focusing on subsequent macular edema

Nicole Stuebiger; Luca Mautone; Laura Ponti; Carsten Grohmann; Katharina Mueller; Martin S. Spitzer

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):639.

ARVO Annual Meeting Abstract June 2025

OCT-based reflectivity analysis using multiple en face intensity projections for detection of central retinal artery occlusion

Carsten Grohmann; Alessandra Walter; Ansgar Beuse; Maximilian Schultheiss; Sven Poli; Martin S. Spitzer; Karl-Ulrich Bartz-Schmidt; Daniel A. Wenzel

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4239.

ARVO Annual Meeting Abstract June 2025

Layer-Specific Proteomic Profiling of the Human Cornea Reveals Insights into Structure and Biological Function

Hauke Matthias Schadwinkel; Paula Christel Nissen; Jan Hahn; Manuela Moritz; Stephan J. Linke; Andrea Hassenstein; Hartmut Schlüter; Martin S. Spitzer; Maria Steuernagel

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2305.

ARVO Annual Meeting Abstract June 2025

Deep Learning for Automated Detection of Retinal Detachment: Evaluating Duration and Macular Status

Inês Valente Lopes; Ansgar Beuse; Christos Skevas; Carsten Grohmann; Martin S. Spitzer

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2799.

ARVO Annual Meeting Abstract June 2025

Patients' views on climate change, health and sustainability

Denise Yang-Seeger; Annkathrin Schellstede; Laurenz JB Pauleikhoff; Martin S. Spitzer; Johannes Birtel

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2057.

ARVO Annual Meeting Abstract June 2025

Hamburg City Health Study: Design and ocular baseline characteristics of the first 10,000 participants

Ansgar Beuse; Inga Hoppert; Christian Wolfram; Martin S. Spitzer; Johannes Birtel; Carsten Grohmann

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2009.

ARVO Annual Meeting Abstract June 2025

Travel – associated emissions of intravitreal injections

Johannes Birtel; Annkathrin Schellstede; Laurenz JB Pauleikhoff; Martin S. Spitzer; Denise Yang-Seeger

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4119.

Retina July 2024

OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy

PDF

Wei Chieh Huang; Christina M. Ohnsman; Yevgeniya Atiskova; Paulo Falabella; Martin S. Spitzer; Angela Schulz; Simon Dulz
TAGS: biological markers, enzyme replacement therapy, retinal degeneration, fovea centralis, parafoveal region
Invest. Ophthalmol. Vis. Sci.. 2024; 65(8):45. https://doi.org/10.1167/iovs.65.8.45

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

REVISION – Early Reperfusion Therapy with Alteplase for Recovery of Vision in Acute Central Retinal Artery Occlusion: A Phase III Double-Blind Randomized Placebo-Controlled Trial

Daniel A. Wenzel; Caroline J. Gassel; Sven Poli; Karl Ulrich Bartz-Schmidt; Spyridon Dimopoulos; Maximilian Schultheiss; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1738.

ARVO Annual Meeting Abstract June 2024

Liposomal Cyclosporine A as a Well-Tolerated Topical Treatment Alternative in Ocular Graft-versus-Host-Disease

Johannes Aaron Pille; Julian Ueberschaar; Mona Karsten; Martin Stephan Spitzer; Nicole Stuebiger

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1977.

ARVO Annual Meeting Abstract June 2024

Real-World efficacy and safety of dexamethasone and fluocinolone acetonide intravitreal implants in patients with non-infectious uveitis

Aydin Özen; Carsten Grohmann; Yevgeniya Atiskova; Martin Stephan Spitzer; Nicole Stuebiger; Johannes Birtel

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2622.

ARVO Annual Meeting Abstract June 2023

Intravitreal aflibercept 8 mg injection in patients with neovascular age-related macular degeneration: 48-week results from the Phase 3 PULSAR trial

Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):461.

ARVO Annual Meeting Abstract June 2023

A modified Pediatric Eye Questionnaire (PedEyeQ) to determine quality of life and functional vision among patients with late-infantile CLN2 disease

Simon Dulz; Martin Stephan Spitzer; Yevgeniya Atiskova

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4122.

ARVO Annual Meeting Abstract June 2023

Epidemiology of uveitis exemplified at a european university uveitis center

Nicole Stuebiger; Lennart Schoenborn; Bettina Fuisting; Martin Stephan Spitzer; Sanaz Farrokhi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4837.

ARVO Annual Meeting Abstract June 2022

Progressive retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in classic late-infantile CLN2 disease

Yevgeniya Atiskova; Christoph Schwering; Jan Wildner; Christoph Spartalis; Frank Schüttauf; Udo Bartsch; Eva Wibbeler; Miriam Nickel; Martin Spitzer; Angela Schulz; Simon Dulz

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4526 – F0313.

ARVO Annual Meeting Abstract June 2022

The challenge of treating the severest forms of chronic non-infectious posterior and panuveitis

Christoph Spartalis; Nicole Stübiger; Martin Spitzer; Udo Bartsch; Yevgeniya Atiskova

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3203 – A0429.

ARVO Annual Meeting Abstract June 2021

Comparison of peripapillary and perimacular flow density of POAG eyes with normal IOP under Tafluprost therapy compared with post-surgery eyes

Hannah Weindler; Martin Stephan Spitzer; Maximilian Schultheiß; Robert Kromer

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1025.

ARVO Annual Meeting Abstract June 2020

A clinical grading scale to assess ocular involvement in juvenile CLN3 disease

Simon Dulz; Jan Wildner; Christoph Schwering; Miriam Nickel; Eva Wibbeler; Martin S Spitzer; Angela schulz; Yevgeniya Atiskova

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1054.

ARVO Annual Meeting Abstract July 2019

Thiolated cross-linked hydrogel as a vitreous substitute – a 6-month follow-up study

Lisa Pohl; Nele Heider; Jose Hurst; Martin Prinz; Christine Hohenadl; Charlotte Reither; Kai Januschowski; Sven Schnichels; Martin Spitzer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6608.

ARVO Annual Meeting Abstract July 2019

Ahmed valve implantation for secondary glaucoma in elderly uveitis patients

Nils Steinhorst Steinhorst; Maria Katharina Casagrande; Martin Spitzer; Nicole Stuebiger

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6642.

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Treatment efficacy of adalimumab in ocular sarcoidosis – focusing on subsequent macular edema

OCT-based reflectivity analysis using multiple en face intensity projections for detection of central retinal artery occlusion

Layer-Specific Proteomic Profiling of the Human Cornea Reveals Insights into Structure and Biological Function

Deep Learning for Automated Detection of Retinal Detachment: Evaluating Duration and Macular Status

Patients' views on climate change, health and sustainability

Hamburg City Health Study: Design and ocular baseline characteristics of the first 10,000 participants

Travel – associated emissions of intravitreal injections

OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy

REVISION – Early Reperfusion Therapy with Alteplase for Recovery of Vision in Acute Central Retinal Artery Occlusion: A Phase III Double-Blind Randomized Placebo-Controlled Trial

Liposomal Cyclosporine A as a Well-Tolerated Topical Treatment Alternative in Ocular Graft-versus-Host-Disease

Real-World efficacy and safety of dexamethasone and fluocinolone acetonide intravitreal implants in patients with non-infectious uveitis

Intravitreal aflibercept 8 mg injection in patients with neovascular age-related macular degeneration: 48-week results from the Phase 3 PULSAR trial

A modified Pediatric Eye Questionnaire (PedEyeQ) to determine quality of life and functional vision among patients with late-infantile CLN2 disease

Epidemiology of uveitis exemplified at a european university uveitis center

Progressive retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in classic late-infantile CLN2 disease

The challenge of treating the severest forms of chronic non-infectious posterior and panuveitis

Comparison of peripapillary and perimacular flow density of POAG eyes with normal IOP under Tafluprost therapy compared with post-surgery eyes

A clinical grading scale to assess ocular involvement in juvenile CLN3 disease

Thiolated cross-linked hydrogel as a vitreous substitute – a 6-month follow-up study

Ahmed valve implantation for secondary glaucoma in elderly uveitis patients

To View More...

You must be signed into an individual account to use this feature.